Researcher.Life Logo

Cephalalgia Reports : Impact Factor & More

eISSN: 2515-8163
JournalOpen Access

Key Metrics

SJR
Q4Neurology (clinical)
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cephalalgia Reports

Cephalalgia Reports Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE
Language English
Article Processing ChargesUSD 1500
Publication Time9
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Headache Society
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Cephalalgia Reports ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cephalalgia Reports

Defining response assessment criteria and inadequate response in acute migraine attack: A Delphi expert consensus from headache experts in India
  • 1 Apr 2026
  • Cephalalgia Reports
Galcanezumab-associated interstitial pneumonia in a migraine patient: A case report
  • 1 Apr 2026
  • Cephalalgia Reports
Revealing the immune face: TIM3 as a window into T-cell immunity in migraine? – A retrospective cohort study
  • 1 Apr 2026
  • Cephalalgia Reports
Migraine as an underrecognized functional disability with implications for driving safety
  • 1 Apr 2026
  • Cephalalgia Reports
Non-headache symptoms and rapid number naming task scores during migraine phases including headache, prodrome, postdrome and non-migraine headache attacks versus interictal state: A longitudinal cohort study
  • 1 Mar 2026
  • Cephalalgia Reports
Use of mediation modeling to examine the relationships among treatment with rimegepant, headache pain severity, and functional disability in patients with migraine
  • 1 Mar 2026
  • Cephalalgia Reports
Defining response assessment criteria and inadequate response in acute migraine attack: A Delphi expert consensus from headache experts in India
  • 1 Apr 2026
  • Cephalalgia Reports
Galcanezumab-associated interstitial pneumonia in a migraine patient: A case report
  • 1 Apr 2026
  • Cephalalgia Reports
Revealing the immune face: TIM3 as a window into T-cell immunity in migraine? – A retrospective cohort study
  • 1 Apr 2026
  • Cephalalgia Reports
Migraine as an underrecognized functional disability with implications for driving safety
  • 1 Apr 2026
  • Cephalalgia Reports
Non-headache symptoms and rapid number naming task scores during migraine phases including headache, prodrome, postdrome and non-migraine headache attacks versus interictal state: A longitudinal cohort study
  • 1 Mar 2026
  • Cephalalgia Reports
Use of mediation modeling to examine the relationships among treatment with rimegepant, headache pain severity, and functional disability in patients with migraine
  • 1 Mar 2026
  • Cephalalgia Reports

FAQs on Cephalalgia Reports